Recombinant epstein-barr virus protein and its use in vaccine

Details Recombinant epstein-barr virus protein and its use in vaccine Recombinant epstein-barr virus protein and its use in vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/38 (2006.01) A61K 39/245 (2006.01) C07K 14/05 (2006.01) C12N 5/10 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2156719

The present invention provides recombinant polypeptides based on the 66 kd serine- and threonine-rich portion of gp350/220 of EBV and the recombinant polypeptide gp350/220. Such polypeptides are useful as vaccines effective against Epstein-Barr virus (EBV) infection.

Affiliated with

Also associated with

Rating

Recombinant epstein-barr virus protein and its use in vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant epstein-barr virus protein and its use in vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant epstein-barr virus protein and its use in vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1868138